Katogen

0 reviews

Katogen is a biopharma consulting and advisory firm founded in 2016 and headquartered in Boston, MA. Founded by Doug Drysdale, a biopharma executive with 35+ years of operator experience, including 18 years in CEO roles, including at Alvogen - a global generics and specialty pharma company - and Cybin, a clinical-stage psychedelic medicine company, Drysdale has completed 17 acquisitions and raised over USD 4 billion in growth capital across the biopharma sector. Katogen advises CEOs, founders, and executive teams at growth-stage and mid-sized biopharma and life sciences companies on strategic planning, M&A, integration, capital raises, development planning, novel modalities, drug delivery, supply chain, and reimbursement strategy.